11 pending office actions • 9 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Neurodiagnostics LLC | 2 |
| Biovena Science, LLC | 2 |
| UNIVERSIDAD DE CONCEPCION | 1 |
| Maddon Advisore LLC | 1 |
| Neurovision Imaging, Inc. | 1 |
| Neurogx LLC | 1 |
| AgeLess Sciences, Inc. | 1 |
| Maddon Advisors LLC | 1 |
| Amabiotics | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18747563 | Antibodies to Andes Hantavirus, and Methods for Using Same | UNIVERSIDAD DE CONCEPCION | BLUMEL, BENJAMIN P | 1671 | Final Rejection | Jun 19, 2024 |
| 18698856 | ACE2-Targeted Compositions and Methods for Treating COVID-19 | Maddon Advisore LLC | SHUPE, ELIZABETH A | 1643 | Non-Final OA | Apr 05, 2024 |
| 18550321 | Biofluid-Based Methods for Diagnosing Alzheimer’s Disease-Associated Conditions | Neurovision Imaging, Inc. | BERHANE, SELAM | 1675 | Non-Final OA | Sep 13, 2023 |
| 18295893 | Synchronized Cell-Based Compositions | Neurogx LLC | MYERS, CARLA J | 1682 | Non-Final OA | Apr 05, 2023 |
| 18062642 | Lymphocyte-Based PKCe Test for Alzheimer's Disease | Neurodiagnostics LLC | NICOL, ALEXANDER W | 1634 | Final Rejection | Dec 07, 2022 |
| 17795294 | Compositions and Methods for Treating Aging-Related Disorders | AgeLess Sciences, Inc. | KETCHAM, KAREN A | 1614 | Final Rejection | Jul 26, 2022 |
| 17499012 | ACE2-Targeted Compositions and Methods for Treating COVID-19 | Maddon Advisors LLC | SHUPE, ELIZABETH A | 1643 | Final Rejection | Oct 12, 2021 |
| 17429374 | Methods for Diagnosing Alzheimer's Disease Based on Cell Growth Rate, Size and Protein Amount | Neurodiagnostics LLC | SPANGLER, JOSEPH RANKIN | 1656 | Final Rejection | Aug 09, 2021 |
| 17277342 | Octreotide Microsphere-Based Arterial Embolization for Treating Obesity | Biovena Science, LLC | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Mar 18, 2021 |
| 17277400 | Flutamide Microsphere-Based Arterial Embolization for Treating Prostate Disorders | Biovena Science, LLC | AL-AWADI, DANAH J | 1615 | Final Rejection | Mar 18, 2021 |
| 16977979 | COMPOUNDS FOR TREATING ALZHEIMER’S DISEASE | Amabiotics | KOSTURKO, GEORGE W | 1621 | Non-Final OA | Sep 03, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial